ArticleJournal of hematology & oncology2016

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development.

Mª Carmen Herrero-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.